BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 19361421)

  • 1. Human immunoglobulin repertoires against tetanus toxoid contain a large and diverse fraction of high-affinity promiscuous V(H) genes.
    de Kruif J; Kramer A; Visser T; Clements C; Nijhuis R; Cox F; van der Zande V; Smit R; Pinto D; Throsby M; Logtenberg T
    J Mol Biol; 2009 Apr; 387(3):548-58. PubMed ID: 19361421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for both H and L chain V regions, VH and VK joining amino acids, and the unique H chain D region for the high affinity binding of an anti-phosphotyrosine antibody.
    Ruff-Jamison S; Glenney JR
    J Immunol; 1993 Apr; 150(8 Pt 1):3389-96. PubMed ID: 7682239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of promiscuity in autoantigen-specific H and L chain combinations as revealed by human H and L chain "roulette".
    Portolano S; Chazenbalk GD; Hutchison JS; McLachlan SM; Rapoport B
    J Immunol; 1993 Feb; 150(3):880-7. PubMed ID: 8423344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the horse V(H) repertoire and comparison with the human IGHV germline genes, and sheep, cattle and pig V(H) sequences.
    Almagro JC; Martinez L; Smith SL; Alagon A; Estevez J; Paniagua J
    Mol Immunol; 2006 Apr; 43(11):1836-45. PubMed ID: 16337682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and validation of a synthetic VH repertoire with tailored diversity for protein recognition.
    Almagro JC; Quintero-Hernández V; Ortiz-León M; Velandia A; Smith SL; Becerril B
    J Mol Recognit; 2006; 19(5):413-22. PubMed ID: 16881059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens.
    Lloyd C; Lowe D; Edwards B; Welsh F; Dilks T; Hardman C; Vaughan T
    Protein Eng Des Sel; 2009 Mar; 22(3):159-68. PubMed ID: 18974080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity.
    Masuda K; Sakamoto K; Kojima M; Aburatani T; Ueda T; Ueda H
    FEBS J; 2006 May; 273(10):2184-94. PubMed ID: 16649995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of the light chain for the epitope specificity of human anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients.
    Hoet RM; Pieffers M; Stassen MH; Raats J; de Wildt R; Pruijn GJ; van den Hoogen F; van Venrooij WJ
    J Immunol; 1999 Sep; 163(6):3304-12. PubMed ID: 10477600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation.
    Figini M; Marks JD; Winter G; Griffiths AD
    J Mol Biol; 1994 May; 239(1):68-78. PubMed ID: 8196048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of expressed V and J regions of immunoglobulin light chains in Xenopus laevis.
    Stewart SE; Du Pasquier L; Steiner LA
    Eur J Immunol; 1993 Aug; 23(8):1980-6. PubMed ID: 8344363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cloning of variable region genes of anti-tetanus toxoid antibody and their expression as three kinds of engineered antibodies in E. coli].
    Zan H; Yeh M
    Shi Yan Sheng Wu Xue Bao; 1997 Sep; 30(3):285-92. PubMed ID: 11039023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the human antibody repertoire to exogenous antigens. Characterization of the H and L chain V region gene segments from anti-hepatitis B virus antibodies.
    Andris JS; Ehrlich PH; Ostberg L; Capra JD
    J Immunol; 1992 Dec; 149(12):4053-9. PubMed ID: 1460290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.
    Schier R; McCall A; Adams GP; Marshall KW; Merritt H; Yim M; Crawford RS; Weiner LM; Marks C; Marks JD
    J Mol Biol; 1996 Nov; 263(4):551-67. PubMed ID: 8918938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing.
    Meijer PJ; Andersen PS; Haahr Hansen M; Steinaa L; Jensen A; Lantto J; Oleksiewicz MB; Tengbjerg K; Poulsen TR; Coljee VW; Bregenholt S; Haurum JS; Nielsen LS
    J Mol Biol; 2006 May; 358(3):764-72. PubMed ID: 16563430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of chicken single chain antibody variable fragments (scFv) that differentiate and neutralize infectious bursal disease virus (IBDV).
    Sapats SI; Heine HG; Trinidad L; Gould GJ; Foord AJ; Doolan SG; Prowse S; Ignjatovic J
    Arch Virol; 2003 Mar; 148(3):497-515. PubMed ID: 12607101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making antibody fragments using phage display libraries.
    Clackson T; Hoogenboom HR; Griffiths AD; Winter G
    Nature; 1991 Aug; 352(6336):624-8. PubMed ID: 1907718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.